Valproic acid: a potential role in treating latent HIV infection

This publication has 11 references indexed in Scilit:

• Depletion of latent HIV-1 infection in vivo: a proof-of-concept study
  The Lancet, 2005
• The targeting of primary effusion lymphoma cells for apoptosis by inducing lytic replication of human herpesvirus 8 while blocking virus production
  Blood, 2005
• Valproic Acid Alters Chromatin Structure by Regulation of Chromatin Modulation Proteins
  Cancer Research, 2005
• Effects of Valproic Acid Coadministration on Plasma Efavirenz and Lopinavir Concentrations in Human Immunodeficiency Virus-Infected Adults
  Antimicrobial Agents and Chemotherapy, 2004
• Coaxing HIV-1 from resting CD4 T cells
  AIDS, 2004
• HIV-1 Viremia Prevents the Establishment of Interleukin 2–producing HIV-specific Memory CD4+ T Cells Endowed with Proliferative Capacity
  The Journal of Experimental Medicine, 2003
• Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells
  Nature Medicine, 2003
• Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy
  Nature Medicine, 1999
• Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
  Nature, 1997
• Sodium Valproate, an Anticonvulsant Drug, Stimulates Human Immunodeficiency Virus Type 1 Replication Independently of Glutathione Levels
  Journal of General Virology, 1996